Rates of MRSA could be cut by a third if wards are treated with a new cleaning product rather than with standard bleach, new research suggests.
In spite of recent progress in tackling superbug infections, thousands of patients still die every year, but the 11-month study at Manchester Royal Infirmary suggests that the new product, Byotrol, could be a useful tool in the fight to get the problem under control after it was found to reduce MRSA levels by a third.
During the study, carried out by Glasgow University, staff on two general medical wards used Byotrol while two other wards were treated with the NHS’s usual cleaning bleach.
Lead researcher Dr Andrew Dodgson, a consultant microbiologist, described the results as being ‘very impressive’. He added: ‘Cutting the levels of pathogens on the wards reduces the risk to patients of picking up an infection.’
Earlier tests had been conducted at Glasgow Royal Infirmary, where it was found that Byotrol cut levels of MRSA by half.